Jerusalem, Israel | Xinhua | A new Israeli-led study has found that the fourth dose of COVID-19 vaccine is effective for protecting people who are 60 and older, Israel’s largest healthcare organization Clalit said on Thursday. The study found that a fourth dose can reduce the possibilities of symptomatic infection, hospitalization, …
Read More »Pfizer 2022 guidance comes shy of expectations despite strong growth projection
New York, U.S. | Xinhua | U.S. pharmaceutical company Pfizer Inc. on Tuesday presented weaker-than-expected operating guidance for 2022 leading to material loss of its stock price. Pfizer expects to realize 98 billion to 102 billion U.S. dollars of revenues in 2022 and the mid-point of the guidance range represents a …
Read More »Pfizer, BioNTech start clinical trial of Omicron-specific COVID-19 vaccine
Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer have started clinical trials of an Omicron-based COVID-19 vaccine candidate in healthy adults 18 through 55 years of age, the companies said on Tuesday. The trials would evaluate the safety, tolerability and immunogenicity of the vaccine candidate, according …
Read More »U.S. orders more pills from Pfizer amid Omicron dominance in 3rd year of pandemic
New York, U.S. | Xinhua | Omicron was officially announced on Tuesday as the absolutely dominant variant of COVID-19 in the United States, as the country is entering the third year of the pandemic, with more curing pills ordered from Pfizer while the federal government’s policies criticized as murky. OMICRON DOMINANCE …
Read More »U.S. FDA authorizes first oral antiviral for COVID-19 treatment
Washington, U.S. | Xinhua | The U.S. Food and Drug Administration on Wednesday authorized Pfizer’s oral antiviral tablets for the treatment of mild-to-moderate COVID-19, the first pill approved for COVID-19 treatment in the country. The pill, called Paxlovid, is authorized for use in adults and pediatric patients 12 years of age …
Read More »EMA recommends emergency use of Pfizer COVID-19 pill
The Hague, Netherlands | Xinhua | The European Medicines Agency (EMA) on Thursday issued advice on the emergency use of Pfizer’s COVID-19 pill called Paxlovid. The European Union (EU) drug regulator said the medicine, which is not yet authorized in the EU, can be used to treat adults with COVID-19 who …
Read More »Pfizer confirms high efficacy of COVID-19 antiviral pill
New York, U.S. | Xinhua | U.S. pharmaceutical giant Pfizer Inc. Tuesday said final results show that its novel COVID-19 oral antiviral tablets could reduce risk of hospitalization or death by close to 90 percent for high-risk patients. The results, based on an analysis of over 2,000 patients in a phase …
Read More »Booster shot provides protection against Omicron: Pfizer
New York, U.S. | Xinhua | A booster shot of COVID-19 vaccine would provide enough protection against the Omicron variant while two doses may not be sufficient, said COVID-19 vaccine developers Pfizer Inc. and BioNTech SE on Wednesday. Three doses of the Pfizer-BioNTech COVID-19 vaccine would generate sufficient serum antibodies to …
Read More »Biden urges calm over Omicron COVID-19 variant, promises efforts for modified vaccines
Washington, U.S. | Xinhua | U.S. President Joe Biden on Monday sought to reassure the country about the new Omicron variant of the coronavirus, telling Americans that his administration was working with vaccine manufacturers to modify vaccines and booster shots should that prove necessary. “We’re throwing everything we have at this …
Read More »Pfizer bullies governments worldwide in COVID-19 vaccine contracts: report
Washington, U.S. | Xinhua | U.S. multinational pharmaceutical and biotechnology corporation Pfizer has been bullying governments around the world in COVID-19 vaccine contracts, said a recent report. “The contracts offer a rare glimpse into the power one pharmaceutical corporation has gained to silence governments, throttle supply, shift risk and maximize profits …
Read More »